Journal rankings · indicator year 2018
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2018
Biochemistry, Genetics and Molecular Biology journal rankings 2018
1,365 ranked journals · Field in Life Sciences
Biochemistry, Genetics and Molecular Biology has 1,365 ranked journals in 2018. The median journal has an OJR of 0.92, below the world average of 1.00, unchanged on 2017; Q1 starts at OJR 1.44. The top three are Cell, Nature Genetics, and Pharmacological Reviews.
Ranks and citation indicators: 2018. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2015–2017, the window the 2018 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Biochemistry, Genetics and Molecular Biology (14)
Up to Life Sciences1,365 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2017. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2015–2017, the window the 2018 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2015–2017 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2009 to 2018. | Compare |
|---|---|---|---|---|---|---|---|
1CellCell Press · United States | 9.81Q1 | 28.47 4.16 up from 2017 | 1,917 | 100% | $11,400 | ||
2Nature GeneticsNature Portfolio · United States | 9.20Q1 | 22.22 1.01 down from 2017 | 812 | 77% | $12,690 | ||
3Pharmacological ReviewsAmerican Society for Pharmacology and Experimental Therapeutics · United States | 7.79Q1 | 20.58 0.35 down from 2017 | 73 | 69% | $4,500 | ||
4NatureNature Portfolio · United Kingdom | 7.29Q1 | 14.69 0.68 up from 2017 | 9,150 | 53% | $12,690 | ||
5Inflammatory Intestinal DiseasesOAKarger Publishers · Switzerland | 6.38Q1 | 13.07 10.54 down from 2017 | 45 | 100% | $990 | ||
6Science AdvancesOAAmerican Association for the Advancement of Science · United States | 6.29Q1 | 15.02 0.96 up from 2017 | 1,530 | 100% | $4,500 | ||
7Cell MetabolismCell Press · United States | 6.24Q1 | 17.68 1.20 up from 2017 | 734 | 100% | $10,400 | ||
8FEMS Microbiology ReviewsOAOxford University Press · Netherlands | 6.13Q1 | 12.39 1.37 down from 2017 | 160 | 89% | $3,297 | ||
9Nature Ecology & EvolutionNature Portfolio · United Kingdom | 5.76Q1 | 9.80 0.64 up from 2017 | 384 | 52% | $12,690 | ||
10Nature Cell BiologyNature Portfolio · United Kingdom | 5.56Q1 | 13.76 3.50 down from 2017 | 520 | 54% | $12,690 | ||
11Fungal DiversitySpringer Science+Business Media · Netherlands | 5.50Q1 | 15.86 0.64 up from 2017 | 70 | 29% | $3,490 | ||
12Nature BiotechnologyNature Portfolio · United States | 5.31Q1 | 11.66 1.47 down from 2017 | 1,035 | 34% | $12,690 | ||
13Nature CommunicationsOANature Portfolio · United Kingdom | 5.30Q1 | 13.84 0.58 down from 2017 | 11,182 | 100% | $6,990 | ||
14Nature ProtocolsNature Portfolio · United States | 5.24Q1 | 13.22 0.81 down from 2017 | 450 | 58% | — | ||
15Nature MicrobiologyNature Portfolio · United Kingdom | 5.13Q1 | 12.29 2.21 up from 2017 | 469 | 65% | $12,690 | ||
16Biotechnology AdvancesElsevier BV · United Kingdom | 5.13Q1 | 11.33 1.91 down from 2017 | 343 | 35% | $5,460 | ||
17Current Protocols in BioinformaticsWiley · United States | 5.10Q1 | 19.38 5.89 up from 2017 | 61 | 37% | $5,050 | ||
18Journal of Extracellular VesiclesOATaylor & Francis · United States | 5.08Q1 | 12.15 6.82 down from 2017 | 118 | 100% | $4,410 | ||
19Cell Host & MicrobeCell Press · United States | 5.05Q1 | 11.88 1.79 down from 2017 | 606 | 100% | $10,400 | ||
20Genome biologyOABioMed Central · United Kingdom | 4.93Q1 | 14.47 0.41 up from 2017 | 751 | 100% | $5,490 | ||
21MicrobiomeOABioMed Central · United Kingdom | 4.93Q1 | 13.39 1.54 up from 2017 | 294 | 100% | $4,990 | ||
22Cell stem cellElsevier BV · United States | 4.71Q1 | 13.38 1.54 down from 2017 | 612 | 100% | $10,400 | ||
23Molecular Biology and EvolutionOAOxford University Press · United States | 4.66Q1 | 13.65 4.57 up from 2017 | 999 | 86% | $3,418 | ||
24Bone ResearchOASpringer Nature · China | 4.59Q1 | 12.09 1.28 up from 2017 | 78 | 100% | $3,405 | ||
25Nature MethodsNature Portfolio · United States | 4.51Q1 | 12.39 1.85 up from 2017 | 1,231 | 39% | $12,690 | ||
26Circulation ResearchLippincott Williams & Wilkins · United States | 4.50Q1 | 11.90 0.38 down from 2017 | 960 | 43% | — | ||
27Journal of Clinical InvestigationOAAmerican Society for Clinical Investigation · United States | 4.47Q1 | 11.73 0.89 down from 2017 | 1,294 | 100% | $5,200 | ||
28Drug Resistance UpdatesElsevier BV · United Kingdom | 4.43Q1 | 13.69 0.65 up from 2017 | 67 | 17% | $5,410 | ||
29ACS Central ScienceOAAmerican Chemical Society · United States | 4.42Q1 | 13.32 2.30 up from 2017 | 330 | 100% | $0 listed | ||
30Progress in Lipid ResearchElsevier BV · United Kingdom | 4.38Q1 | 8.66 1.64 up from 2017 | 126 | 29% | $5,530 | ||
31Studies in MycologyElsevier BV · Netherlands | 4.36Q1 | 8.84 4.32 down from 2017 | 53 | 100% | $1,430 | ||
32Molecular CellElsevier BV · United States | 4.21Q1 | 13.32 0.02 up from 2017 | 1,194 | 100% | $10,400 | ||
33Nature Biomedical EngineeringNature Portfolio · United Kingdom | 4.10Q1 | 10.24 0.07 up from 2017 | 156 | 51% | $12,690 | ||
34Proceedings of the National Academy of SciencesNational Academy of Sciences · United States | 4.07Q1 | 9.78 0.08 down from 2017 | 11,309 | 98% | — | ||
35Science Translational MedicineAmerican Association for the Advancement of Science · United States | 4.00Q1 | 10.48 0.46 up from 2017 | 1,374 | 42% | — | ||
36ScienceAmerican Association for the Advancement of Science · United States | 3.91Q1 | 7.87 0.21 up from 2017 | 15,057 | 19% | — | ||
37Genetics in MedicineElsevier BV · United States | 3.89Q1 | 7.21 1.01 down from 2017 | 636 | 99% | $5,110 | ||
38PLoS BiologyOAPublic Library of Science · United States | 3.88Q1 | 9.78 0.44 up from 2017 | 776 | 100% | $5,500 | ||
39The American Journal of Human GeneticsElsevier BV · United States | 3.75Q1 | 10.29 1.68 up from 2017 | 677 | 97% | $5,150 | ||
40Pharmacology & TherapeuticsElsevier BV · United States | 3.70Q1 | 9.91 0.64 up from 2017 | 418 | 44% | $5,660 | ||
41Nucleic Acids ResearchOAOxford University Press · United Kingdom | 3.65Q1 | 10.95 0.23 up from 2017 | 4,216 | 100% | $3,992 | ||
42Genome MedicineOABioMed Central · United Kingdom | 3.56Q1 | 11.41 2.20 up from 2017 | 369 | 100% | $5,290 | ||
43Nature reviews. CancerNature Portfolio · United Kingdom | 3.55Q1 | 23.92 5.59 up from 2017 | 436 | 34% | — | ||
44TrAC Trends in Analytical ChemistryElsevier BV · Netherlands | 3.53Q1 | 8.59 0.62 up from 2017 | 703 | 25% | $5,150 | ||
45EMBO Molecular MedicineOASpringer Nature · United Kingdom | 3.52Q1 | 9.96 0.22 up from 2017 | 367 | 100% | $7,990 | ||
46Redox BiologyOAElsevier BV · Netherlands | 3.43Q1 | 8.79 1.28 up from 2017 | 599 | 100% | $4,310 | ||
47GigaScienceOAUniversity of Oxford · United Kingdom | 3.41Q1 | 6.81 0.83 down from 2017 | 277 | 100% | $2,638 | ||
48mSystemsOAAmerican Society for Microbiology · United States | 3.37Q1 | 8.14 0.62 up from 2017 | 139 | 100% | $3,500 | ||
49Cell ResearchSpringer Nature · United Kingdom | 3.31Q1 | 9.67 0.48 up from 2017 | 457 | 98% | $5,190 | ||
50Nature Structural & Molecular BiologyNature Portfolio · United States | 3.30Q1 | 10.02 0.79 down from 2017 | 557 | 68% | $12,690 |
Subfields of Biochemistry, Genetics and Molecular Biology, compared.
- Molecular Biology1,155
- Genetics125
- Cancer Research28
- Cell Biology26
- Molecular Medicine10
- Biophysics7
- Clinical Biochemistry6
- Structural Biology3
- Biochemistry2
- Aging1
- Developmental Biology1
- Physiology1
- Biotechnology0
- Endocrinology0
Journals
Citations made in 2018. Corpus-wide, 81.5% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
434 additional Biochemistry, Genetics and Molecular Biology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2015–2017, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2018. Publication window: 2015–2017. How these summaries are calculated
- Ranked journals
- 1,365
- Window papers (baseline)
- 678,826 +1.0% from indicator year 2015
- Median OJR
- 0.925 -4.5% from indicator year 2015
- Rising journals (2025)
- 141Comparison-group list (141)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2015–2017 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 609 | 650 | 696 | 742 | 765 | 806 | 835 | 888 | 919 | 951 | 1,003 | 1,064 | 1,125 | 1,172 | 1,217 | 1,271 | 1,311 | 1,339 | 1,365 | 1,369 | 1,349 | 1,339 | 1,358 | 1,366 | 1,355 | 1,367 | |
| Window papers (baseline) | 310,927 | 335,262 | 354,210 | 375,343 | 388,415 | 415,247 | 441,606 | 472,036 | 497,712 | 532,780 | 565,943 | 595,190 | 615,359 | 631,115 | 652,778 | 672,042 | 683,714 | 684,441 | 678,826 | 679,352 | 690,127 | 717,801 | 750,552 | 768,440 | 764,327 | 768,613 | |
| Median OJR | 0.628 | 0.634 | 0.68 | 0.76 | 0.81 | 0.8465 | 0.872 | 0.894 | 0.921 | 0.95 | 0.98 | 1.03 | 1.02 | 0.990 | 0.986 | 0.97 | 0.96 | 0.93 | 0.925 | 0.915 | 0.912 | 0.90 | 0.890 | 0.8474 | 0.853 | 0.871 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 1.9% | 1,206 journals |
| Retracted papers per 1,000 | Pooled rate: 4.798 per 1,000 | 1,059 journals |
| Output growth | Median: -6.4% | 1,233 journals |
| Open access share | Median: 100.0% | 1,367 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,300 | 943 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 24.4% | 1,335 journals |
| Review share | Median: 0.3% | 1,367 journals |
| Articles-only OJR | Median: 0.87 | 1,336 journals |
| Uncited share | Median: 22.7% | 1,367 journals |
| Citation concentration | Median: 42.1% | 1,363 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.